Pedro Valdivielso Selected Research

Pedro Valdivielso Research Topics

Disease

12	Cardiovascular Diseases (Cardiovascular Disease) 05/2024 - 04/2010
11	Hypertriglyceridemia 05/2024 - 10/2002
9	Arteriosclerosis 11/2022 - 03/2011
7	Hypertension (High Blood Pressure) 01/2023 - 07/2008
6	Pancreatitis 10/2023 - 06/2009
5	Atherosclerosis 01/2023 - 07/2012
5	Dyslipidemias (Dyslipidemia) 01/2023 - 01/2017
5	Type 2 Diabetes Mellitus (MODY) 10/2014 - 10/2007
4	Pseudoxanthoma Elasticum (Gronblad Strandberg Syndrome) 03/2023 - 12/2019
4	Hypercholesterolemia 11/2022 - 08/2002
3	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 03/2023 - 11/2018
3	Obesity 09/2020 - 06/2009
3	Rheumatoid Arthritis 08/2020 - 01/2016
3	Inflammation (Inflammations) 03/2020 - 12/2015
3	Peripheral Arterial Disease 10/2014 - 07/2008
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 11/2022 - 01/2019
2	Hyperlipidemias (Hyperlipidemia) 01/2022 - 01/2009
2	Inborn Genetic Diseases (Disease, Hereditary) 11/2021 - 05/2020
2	Costello Syndrome 12/2020 - 11/2018
2	Insulin Resistance 03/2020 - 01/2016
2	Fatty Liver 03/2020 - 05/2017
2	Homozygous Familial Hypercholesterolemia 01/2019 - 03/2015
1	Abdominal Pain (Pain, Abdominal) 10/2023
1	Xanthomatosis (Xanthoma) 10/2023
1	Hypobetalipoproteinemias (Hypobetalipoproteinemia) 09/2023
1	Atherosclerotic Plaque (Atheroma) 01/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 11/2021
1	Body Weight (Weight, Body) 05/2021
1	Immunoglobulin G4-Related Disease 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2020
1	Testicular Neoplasms (Testicular Cancer) 03/2020
1	Prediabetic State (Prediabetes) 07/2019
1	Chronic Renal Insufficiency 01/2019
1	Vascular Calcification 01/2019
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2018
1	Arterial calcification of infancy 01/2018
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 09/2015
1	Diabetic Nephropathies (Diabetic Nephropathy) 09/2014
1	Vascular Diseases (Vascular Disease) 10/2007
1	Nephrotic Syndrome (Syndrome, Nephrotic) 04/2003

Drug/Important Bio-Agent (IBA)

20	LipidsIBA 05/2024 - 10/2007
13	Triglycerides (Triacylglycerol)IBA 05/2024 - 10/2007
7	LDL CholesterolIBA 05/2024 - 07/2008
6	Lipoproteins (Lipoprotein)IBA 09/2023 - 01/2009
5	HDL CholesterolIBA 05/2024 - 07/2008
5	ApolipoproteinsIBA 01/2022 - 02/2012
4	Apolipoprotein B-48IBA 01/2022 - 01/2009
3	diphosphoric acid (pyrophosphoric acid)IBA 03/2023 - 01/2018
3	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 03/2023 - 06/2009
3	CholesterolIBA 11/2021 - 05/2019
3	oxidized low density lipoproteinIBA 11/2021 - 03/2015
3	Apolipoproteins E (ApoE)IBA 02/2012 - 06/2009
2	Alkaline PhosphataseIBA 03/2023 - 12/2019
2	CytokinesIBA 01/2022 - 01/2016
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 05/2021 - 01/2009
2	ChylomicronsIBA 12/2020 - 12/2015
2	EnzymesIBA 12/2019 - 01/2018
2	Blood Glucose (Blood Sugar)IBA 07/2019 - 04/2010
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 07/2019 - 07/2008
2	Apolipoprotein C-II (ApoC2)IBA 11/2018 - 06/2009
2	Lipase (Acid Lipase)FDA Link 06/2009 - 07/2008
2	Atorvastatin (Lipitor)FDA Link 04/2003 - 08/2002
1	Lansoprazole (Prevacid)FDA LinkGeneric 03/2023
1	CreatinineIBA 01/2023
1	C-Reactive ProteinIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Biomarkers (Surrogate Marker)IBA 06/2021
1	SugarsIBA 05/2021
1	Fibric Acids (Fibrates)IBA 05/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	VLDL LipoproteinsIBA 12/2020
1	Apolipoproteins B (ApoB)IBA 12/2020
1	ElastinIBA 05/2020
1	CalciumIBA 03/2020
1	HDL LipoproteinsIBA 03/2020
1	PCSK9 InhibitorsIBA 05/2019
1	Phosphorus (Red Phosphorus)IBA 01/2019
1	Apolipoprotein B-100 (Apo B 100)IBA 01/2019
1	Proprotein Convertase 9IBA 01/2019
1	Apolipoprotein A-VIBA 11/2018
1	Chylomicron RemnantsIBA 02/2018
1	A-factor (Streptomyces)IBA 01/2018
1	ectonucleotide pyrophosphatase phosphodiesterase 1IBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	Olive OilIBA 05/2017
1	AdipokinesIBA 01/2016
1	Hemoglobins (Hemoglobin)IBA 09/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2012
1	Fluvastatin FDA Link 01/2009
1	Fenofibrate (CiL)FDA LinkGeneric 10/2002

Therapy/Procedure

6	Therapeutics 01/2023 - 08/2002
3	Secondary Prevention 11/2022 - 11/2018
2	Drug Therapy (Chemotherapy) 03/2020 - 06/2009
2	Mediterranean Diet 07/2017 - 05/2017
1	Bariatric Surgery 01/2022
1	Caloric Restriction 05/2021
1	Radiotherapy 03/2020
1	Tertiary Prevention 09/2015
1	Denervation 12/2012